Role of the endothelium on vasoactive agents in patients with liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 7, 2006, Pages 1189-1193

  Battaglia, Samuel ^a   Angus, Peter ^a   Chin Dusting, Jaye P F ^b  

^a AUSTIN HEALTH   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Endothelium; Forearm; Hepatic cirrhosis; Human; Nitric oxide

Indexed keywords

ACETYLCHOLINE; BRADYKININ; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM; HUMAN; LIVER CIRRHOSIS; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

EID: 33745218076     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04451.x     Document Type: Article

References (22)

1. Lunzer MR Newman SP Bernard AG Manghani KK Sherlock SP Ginsburg J. Impaired cardiovascular responsiveness in liver disease. Lancet 1975 2 : 382 5.
2. MacGilchrist AJ Sumner D Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991 13 : 689 94.
3. Ryan J Sudhir K Jennings G Esler M Dudley F. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993 105 : 1167 72.
4. Silva G Navasa M Bosch J et al. Hemodynamic effects of glucagon in portal hypertension. Hepatology 1990 11 : 668 73.
5. Laffi G La Villa G Pinzani M Marra F Gentilini P. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin. Nephrol. 1997 17 : 530 48.
6. Warner L Skorecki K Blendis LM Epstein M. Atrial natriuretic factor and liver disease. Hepatology 1993 17 : 500 13.
7. Kaviani A Ohta M Itani R Sander F Tarnawski AS Sarfeh IJ. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J. Gastrointest. Surg. 1997 1 : 371 6.
8. Wiest R Das S Cadelina G Garcia-Tsao G Milstien S Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 1999 104 : 1223 33.
9. Pizcueta P Pique JM Fernandez M et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992 103 : 1909 15.
10. Chin-Dusting JP Rasaratnam B Jennings GL Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann. Intern. Med. 1997 127 : 985 8.
11. Albillos A Rossi I Cacho G et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am. J. Physiol. 1995 268 : G459 64.
12. Campillo B Chabrier PE Pelle G et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995 22 : 1423 9.
13. Matthews JN Altman DG Campbell MJ Royston P. Analysis of serial measurements in medical research. BMJ 1990 300 : 230 5.
14. Ryan J Jennings G Dudley F Chin-Dusting J. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin. Sci. (Lond.) 1996 91 : 23 8.
15. Cugno M Salerno F Mandelli M Lorenzano E Paonessa R Agostoni A. Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis. Thromb. Res. 1995 78 : 277 82.
16. Kneale BJ Chowienczyk PJ Brett SE Coltart DJ Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J. Am. Coll. Cardiol. 2000 36 : 1233 8.
17. Majmudar NG Robson SC Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J. Clin. Endocrinol. Metab. 2000 85 : 1577 83.
18. Sarabi M Lind L Millgard J et al. Local vasodilatation with metacholine, but not with nitroprusside, increases forearm glucose uptake. Physiol. Res. 1999 48 : 291 5.
19. Dietz NM. Gender and nitric oxide-mediated vasodilation in humans. Lupus 1999 8 : 402 8.
20. Pacca SR de Azevedo AP De Oliveira CF De Luca IM De Nucci G Antunes E. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 2002 39 : 201 7.
21. Moller S Bendtsen F Henriksen JH. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis. Scand. J. Gastroenterol. 2001 36 : 653 7.
22. Kobayashi N Mita S Yoshida K et al. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress. Hypertension 2003 42 : 1004 13.